Search
Novocore: Marketing Application for Pertuzumab Injection Accepted
3 day ago /
Read about 0 minute
Author：小编
Novocore announced that its controlled subsidiary, CSPC Juishi Biopharmaceuticals Co., Ltd., recently received the 'Acceptance Notice' issued by the National Medical Products Administration. The marketing application for Pertuzumab Injection has been accepted. This product is intended for the treatment of HER2-positive breast cancer.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
